Comprehensive Brain Tumor Care in the Era of Targeted Therapies and Novel Imaging Techniques

Monday, May 6, 2024

7:00 AM – 12:00 PM CT

Location: S503ab

Moderator(s)

Alexandra Golby, MD, FAANS

Professor of Neurosurgery
Harvard Medical School Brigham and Women's Hospital
Boston, MA, US
Michael Lim, MD

Professor and Chair of Neurosurgery
Stanford University School of Medicine
Stanford, California, United States

Advances in the diagnosis and treatment of gliomas extend across all disciplines of neuro-oncology. The goal of this course is to provide an update to the audience on the latest developments in tumor biology, molecular diagnosis, imaging techniques and novel therapies. The evolving role of neurosurgeons in clinical trials for brain tumors will also be discussed.

Learning Objectives:

Identify the latest technologies for diagnosing brain tumors.
Compare the state of novel personalized and immunotherapy strategies for gliomas.
Evolve the role of neurosurgeons in brain tumor clinical trials.

Disclosure(s):

Alexandra J. Golby, MD, FAANS: InSightec: Grant/Research Support (Terminated); Johnson & Johnson: Stock Shareholder (excluding mutual funds) (Ongoing); Merke: Stock Shareholder (excluding mutual funds) (Ongoing)

Michael Lim, MD, FAANS: Egret Therapeutics: Ownership or Partnership (Ongoing)

Presentations:

7:00 AM – 7:10 AM CT

Welcome and Introduction
Speaker: Alexandra J. Golby, MD, FAANS – Harvard Medical School Brigham and Women's Hospital
7:11 AM – 7:30 AM CT

Advanced MRI Techniques to Probe Brain Tumor Microenvironment and Improve Monitoring
Speaker: Michael Iv, MD (he/him/his) – Stanford University
7:31 AM – 7:50 AM CT

Liquid Biopsies for Diagnosis and Monitoring
Speaker: Chetan Bettegowda, MD PhD (he/him/his) – Department of Neurosurgery, The Johns Hopkins University School of Medicine
7:51 AM – 8:10 AM CT

Tumor Heterogeneity, Tumor Micro-Environment
Speaker: Charles P. Couturier, MD, PhD (he/him/his) – Brigham and Women's Hospital
8:11 AM – 8:30 AM CT

Methylation Profiling of CNS Tumors
Speaker: Gelareh Zadeh, MD PhD – University of Toronto
8:31 AM – 8:50 AM CT

Raman Spectroscopy and AI for Brain Tumor Diagnosis
Speaker: Daniel Orringer, MD – NYU Langone Health
8:51 AM – 9:10 AM CT

Radiomics and Radiogenomics for Brain Tumor Characterization
Speaker: MacLean Nasrallah, MD, PhD – University of Pennsylvania
9:11 AM – 9:41 AM CT

Beverage Break
9:42 AM – 10:02 AM CT

Targeted Therapies for DIPG
Speaker: Gerald Grant, MD – Duke University
10:03 AM – 10:23 AM CT

Neurosurgeon's Role in Clinical Trials: Neoadjuvant Treatment and Tissue Sampling
Speaker: Nader Sanai, MD – Barrow Neurological Institute
10:24 AM – 10:44 AM CT

Establishing and Working in Consortia for Brain Tumor Clinical Trials
Speaker: Patrick Y. Wen, MD (he/him/his) – Dana-Farber Cancer Institute
10:45 AM – 11:05 AM CT

Personalized Medicine: Microdevices for In-Vivo Therapeutic Evaluation
Speaker: Pierpaolo Peruzzi, MD, PhD – Brigham and Women's Hospital
11:06 AM – 11:26 AM CT

Immunotherapy
Speaker: Linda M. Liau, MD, PhD, MBA (she/her/hers) – UCLA Department of Neurosurgery
11:27 AM – 12:00 PM CT

Open Discussion with Panelists
Speaker: Michael Lim, MD – Stanford University School of Medicine